Revvity (RVTY) Cost of Revenue (2009 - 2026)
Revvity's (RVTY) quarterly Cost of Revenue came in at $323.5 million in Q2 2026, up 11.84% YoY from $289.2 million in Q2 2025, and up 142.19% on a QoQ basis from -$766.7 million in Q4 2025.
Revvity (RVTY) Cost of Revenue (2009 - 2026) Analysis & Trends
Revvity (RVTY) has 18 years of Cost of Revenue data on file, last reported at $323.5 million in Q2 2026.
- Quarterly Cost of Revenue rose 11.84% year-over-year to $323.5 million in Q2 2026, while the trailing twelve-month figure through Apr 2026 was $208.8 million (down 79.85% YoY) and the FY2025 annual result came in at $174.6 million, down 83.24% from the prior year.
- Cost of Revenue grew to $323.5 million in Q2 2026, from -$766.7 million in the prior quarter.
- In the past five years, Cost of Revenue ranged from a high of $368.4 million in Q2 2022 to a low of -$766.7 million in Q4 2025.
- A 5-year average of $222.1 million and a median of $299.2 million in 2024 frame the typical range for Cost of Revenue.
- Annual changes were most pronounced in 2023 — Cost of Revenue gained 27.43% — and 2025, when it slumped 642.0%.
- Tracing RVTY's Cost of Revenue over 5 years: stood at $304.8 million in 2022, then slumped by 41.17% to $179.3 million in 2023, then dropped by 21.1% to $141.5 million in 2024, then tumbled by 642.0% to -$766.7 million in 2025, then jumped by 142.19% to $323.5 million in 2026.
- The last three Cost of Revenue figures came in at $323.5 million (Q2 2026), -$766.7 million (Q4 2025), and $324.3 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cost of Rev (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 234.15 Bn | 230.09 Bn | 8.34 Bn | 3.65 Bn |
| 2 | Danaher | 152.10 Bn | 147.75 Bn | 3.61 Bn | 2.65 Bn |
| 3 | Natera | 48.48 Bn | 47.38 Bn | 486.15 Mn | 266.60 Mn |
| 4 | Agilent Technologies | 44.35 Bn | 42.55 Bn | 990.00 Mn | 845.00 Mn |
| 5 | Iqvia Holdings | 43.68 Bn | 41.60 Bn | 1.44 Bn | 2.93 Bn |
| 6 | Idexx Laboratories | 43.02 Bn | 42.83 Bn | 779.09 Mn | 437.50 Mn |
| 7 | Illumina | 34.39 Bn | 33.22 Bn | 770.00 Mn | 389.00 Mn |
| 8 | Mettler Toledo International | 28.29 Bn | 28.24 Bn | 650.22 Mn | 253.28 Mn |
| 9 | Labcorp Holdings | 27.51 Bn | 27.37 Bn | 1.11 Bn | 2.62 Bn |
| 10 | Revvity | 14.41 Bn | 13.39 Bn | 416.87 Mn | 312.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jul 5, 2026 | 312.82 Mn |
| Jul 5, 2026 | 312.82 Mn |
| Apr 5, 2026 | 323.46 Mn |
| Apr 5, 2026 | 323.46 Mn |
| Dec 28, 2025 | 175.84 Mn |
| Dec 28, 2025 | 175.84 Mn |
| Sep 28, 2025 | 324.35 Mn |
| Sep 28, 2025 | 324.35 Mn |
| Jun 29, 2025 | 327.73 Mn |
| Jun 29, 2025 | 327.73 Mn |
| Mar 30, 2025 | 289.22 Mn |
| Mar 30, 2025 | 289.22 Mn |
| Dec 29, 2024 | 141.46 Mn |
| Dec 29, 2024 | 141.46 Mn |
| Sep 29, 2024 | 299.23 Mn |
| Sep 29, 2024 | 299.23 Mn |
| Jun 30, 2024 | 306.18 Mn |
| Jun 30, 2024 | 306.18 Mn |
| Mar 31, 2024 | 294.87 Mn |
| Mar 31, 2024 | 294.87 Mn |